Consistent with these findings, the analysis of tumor-infiltrating lymphocytes revealed an increase in NK cells and CD4+ T cells in the DPP4-reconstituted group compared with controls, which is consistent with the enhanced in vivo antitumor effect. The gene discussed is DPP4; the disease is neoplasm.